Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis

• Published in: Oncogene Vol. 32; no. 39; pp. 4675 - 4682
• Main Authors: Christie, M, Jorissen, R N, Mouradov, D, Sakthianandeswaren, A, Li, S, Day, F, Tsui, C, Lipton, L, Desai, J, Jones, I T, McLaughlin, S, Ward, R L, Hawkins, N J, Ruszkiewicz, A R, Moore, J, Burgess, A W, Busam, D, Zhao, Q, Strausberg, R L, Simpson, A J, Tomlinson, I P M, Gibbs, P, Sieber, O M
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 26.09.2013
• Subjects: Adenomatous Polyposis Coli - genetics; Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic - genetics; Codon - genetics; Colonic Neoplasms - genetics; Colonic Neoplasms - pathology; Colorectal cancer; Colorectal Neoplasms - genetics; Colorectal Neoplasms - pathology; DNA sequencing; Female; Gene mutations; Genes, APC; Genetic aspects; Genotype; Humans; Identification and classification; Loss of Heterozygosity; Male; Microsatellite Instability; Middle Aged; Mutation; Nucleotide sequencing; Observations; Organ Specificity; Original; Polyposis, Familial; Rectal Neoplasms - genetics; Rectal Neoplasms - pathology; Sequence Deletion; Sigmoid Neoplasms - genetics; Sigmoid Neoplasms - pathology; Single nucleotide polymorphisms; Wnt Signaling Pathway - genetics
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/onc.2012.486

Biallelic protein-truncating mutations in the adenomatous polyposis coli (APC) gene are prevalent in sporadic colorectal cancer (CRC). Mutations may not be fully inactivating, instead producing WNT/β-catenin signalling levels 'just-right' for tumourigenesis. However, the spectrum of optimal APC genotypes accounting for both hits, and the influence of clinicopathological features on genotype selection remain undefined. We analysed 630 sporadic CRCs for APC mutations and loss of heterozygosity (LOH) using sequencing and single-nucleotide polymorphism microarrays, respectively. Truncating APC mutations and/or LOH were detected in 75% of CRCs. Most truncating mutations occurred within a mutation cluster region (MCR; codons 1282-1581) leaving 1-3 intact 20 amino-acid repeats (20AARs) and abolishing all Ser-Ala-Met-Pro (SAMP) repeats. Cancers commonly had one MCR mutation plus either LOH or another mutation 5' to the MCR. LOH was associated with mutations leaving 1 intact 20AAR. MCR mutations leaving 1 vs 2-3 intact 20AARs were associated with 5' mutations disrupting or leaving intact the armadillo-repeat domain, respectively. Cancers with three hits had an over-representation of mutations upstream of codon 184, in the alternatively spliced region of exon 9, and 3' to the MCR. Microsatellite unstable cancers showed hyper-mutation at MCR mono- and di-nucleotide repeats, leaving 2-3 intact 20AARs. Proximal and distal cancers exhibited different preferred APC genotypes, leaving a total of 2 or 3 and 0 to 2 intact 20AARs, respectively. In conclusion, APC genotypes in sporadic CRCs demonstrate 'fine-tuned' interdependence of hits by type and location, consistent with selection for particular residual levels of WNT/β-catenin signalling, with different 'optimal' thresholds for proximal and distal cancers.